BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27816027)

  • 1. Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study.
    Chen L; Yu C; Zhang N; Liu J; Liu W
    Clin Neurol Neurosurg; 2016 Dec; 151():65-69. PubMed ID: 27816027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
    Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
    J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
    Mills KA; Schneider RB; Saint-Hilaire M; Ross GW; Hauser RA; Lang AE; Halverson MJ; Oakes D; Eberly S; Litvan I; Blindauer K; Aquino C; Simuni T; Marras C
    Parkinsonism Relat Disord; 2020 Nov; 80():127-132. PubMed ID: 32987359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.
    Biundo R; Weis L; Bostantjopoulou S; Stefanova E; Falup-Pecurariu C; Kramberger MG; Geurtsen GJ; Antonini A; Weintraub D; Aarsland D
    J Neural Transm (Vienna); 2016 Apr; 123(4):431-8. PubMed ID: 26852137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China.
    Nie K; Zhang Y; Wang L; Zhao J; Huang Z; Gan R; Li S; Wang L
    J Clin Neurosci; 2012 Nov; 19(11):1497-500. PubMed ID: 22959678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease.
    Scheffels JF; Fröhlich L; Kalbe E; Kessler J
    J Neurol Sci; 2020 May; 412():116735. PubMed ID: 32087430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease.
    Ngo AB; Smith KM
    J Parkinsons Dis; 2020; 10(4):1695-1698. PubMed ID: 32925096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between retinal nerve fiber layer thickness and cognitive progression in Parkinson's disease: A longitudinal study.
    Zhang JR; Cao YL; Li K; Wang F; Wang YL; Wu JJ; Pei SF; Chen J; Mao CJ; Liu CF
    Parkinsonism Relat Disord; 2021 Jan; 82():92-97. PubMed ID: 33271462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the ASCO classification with the executive function subscores of the Montreal cognitive assessment in patients with postischemic stroke.
    Washida K; Ihara M; Tachibana H; Sekiguchi K; Kowa H; Kanda F; Toda T
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2250-5. PubMed ID: 25174562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1).
    Wilson H; Pagano G; Yousaf T; Polychronis S; De Micco R; Giordano B; Niccolini F; Politis M
    J Neural Transm (Vienna); 2020 Jan; 127(1):51-59. PubMed ID: 31853652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in idiopathic Parkinson's disease.
    Das D; Biswas A; Roy A; Sauerbier A; Bhattacharyya KB
    Neurol India; 2016; 64(3):419-27. PubMed ID: 27147148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montreal Cognitive Assessment in cryptogenic epilepsy patients with normal Mini-Mental State Examination scores.
    Phabphal K; Kanjanasatien J
    Epileptic Disord; 2011 Dec; 13(4):375-81. PubMed ID: 22258041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.
    Sobreira E; Pena-Pereira MA; Eckeli AL; Sobreira-Neto MA; Chagas MH; Foss MP; Cholerton B; Zabetian CP; Mata IF; Tumas V
    Arq Neuropsiquiatr; 2015 Nov; 73(11):929-33. PubMed ID: 26517216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.
    Ihara M; Okamoto Y; Takahashi R
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):737-41. PubMed ID: 22306380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.